In-house IP roundup: blue-v-blue biologic litigation rises; UPC apathy after new complaint listing; businesses shed patents for cost savings

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

In-house IP roundup: blue-v-blue biologic litigation rises; UPC apathy after new complaint listing; businesses shed patents for cost savings

Blue 168

Patent Strategy, a new service from Managing IP, rounds up the latest news and analysis from patent-focused businesses

splash

Biologics market spurs blue-v-blue litigation for generics and innovators

Zentiva, Insud Pharma and an originator drug company explain how large molecule market dynamics have shifted the litigation format created by small molecule products, turning other generics and innovators into litigation targets. (Read more … ) 


UPC

UPC: businesses apathetic to 2019 complaint listing

In-house counsel explain what they’ve done so far to prepare for the Unified Patent Court, but say they’re unlikely to increase preparations, despite the complaint holding up the system’s creation being moved to this year’s agenda. (Read more … )


Abandon

Patents abandoned by companies to save and make money

Patent departments say financial constraints have compelled more businesses to abandon or sell off less valuable registrations – but they add that they are careful not to get rid of the wrong ones. (Read more … )

Sign up to receive more content like this in Patent Strategy’s weekly newsletter.

more from across site and SHARED ros bottom lb

More from across our site

The Australian IP firm is taking on bigger rivals in Southeast Asia, betting that agility and transparent pricing can help it stand out
The firm has brought in former Weil IP leaders Doug Lumish and Jeff Homrig as it looks to deepen its patent, trade secrets and ITC bench
Bird & Bird helps GSK score a major injunction as the battle to become the UPC’s busiest division tightens, and overall filings reach a new monthly high
CEO Annette Bach explains how the Danish IP consultancy plans to build on its 65% profit growth while keeping external investment off the table for now
Belgian attorneys have revived fax systems to protect clients’ filing rights, while uncertainty over exposed patent data has left firms struggling to answer questions about the breach
In his first interview since leaving Weil Gotshal & Manges, Chris Henry explains why he returned to Latham and how he plans to bolster its tech disputes offering
As GTA VI underlines the extraordinary value of gaming franchises, lawyers at Clifford Chance say investors need to know the IP behind their next deal can deliver the growth they are paying for
As ‘big law’ invests in IP litigation, trial firms are emerging as a valuable source of seasoned courtroom talent
Six hires across the IP spectrum reflect Orrick’s efforts to better serve tech clients across the IP lifecycle
David Stone, partner at White & Case, argues that the government’s planned reforms will modernise and futureproof UK design law, but leave two of the thorniest problems unresolved
Gift this article